Humanized Rodents that Express Heavy Chain Containing VL Domains
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsLynn Macdonald, Cagan Gurer, Karolina A. Meagher, Sean Stevens, Andrew J. Murphy
Life of this patent
Estimating the term…
Loading patent…
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsLynn Macdonald, Cagan Gurer, Karolina A. Meagher, Sean Stevens, Andrew J. Murphy
Estimating the term…
Non-human animals, tissues, cells, and genetic material are provided that comprise a modification of an endogenous non-human heavy chain immunoglobulin sequence and that comprise an ADAM6 activity functional in a rodent (e.g., a mouse), wherein the non-human animals rearrange human immunoglobulin light chain gene segments in the context of heavy chain constant regions and express immunoglobulin-like molecules comprising human immunoglobulin light chain variable domains fused to heavy chain constant domains that are cognate with human immunoglobulin light chain variable domains fused to light chain constant domains.
A non-human animal comprising
A genetically modified non-human animal that comprises
A rodent comprising one or more human immunoglobulin light chain gene segments operably linked to a non-human immunoglobulin heavy chain constant region gene, wherein the rodent expresses one or more ADAM6 proteins.
A method for modifying a heavy chain immunoglobulin locus of a rodent, comprising:
The method according to claim 36, wherein the first and the second modification are made in a single ES cell, and the single ES cell is introduced into a host embryo to make the rodent.
Dependencies are inferred from the claim text.